Jun 132011
Taveira-DaSilva reports an observational series of 19 women treated with sirolimus for lymphangioleiomyomatosis. Of 12 women with chylous pleural effusions, most had a large improvement or resolution in their effusions. Ann Intern Med 2011;154:797-805.
In a randomized trial of 89 LAM patients published in NEJM March 2011, sirolimus reduced decline of lung function.
You may also like -
Sirolimus was helpful for LAM, but with toxicity (RCT, NEJM)
Pulmonary Hypertension Update, Part 1: Classification & Diagnosis (Review, JAMA)
Pleural effusions more common in PAH than believed?
COPD surprise: In majority, FEV1 declines no faster than healthy people's (NEJM)
Thin elderly with mild COPD at highest risk for lung cancer (AJRCCM)Liked this post? Get a weekly email update (no spam, ever), and explore our library of pulmonary and critical care guidelines, practice updates and review articles.